Please use this identifier to cite or link to this item:
http://dspace.dtu.ac.in:8080/jspui/handle/repository/17245
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | DABODIYA, VIVEK | - |
dc.date.accessioned | 2019-12-31T06:30:25Z | - |
dc.date.available | 2019-12-31T06:30:25Z | - |
dc.date.issued | 2016-05 | - |
dc.identifier.uri | http://dspace.dtu.ac.in:8080/jspui/handle/repository/17245 | - |
dc.description.abstract | The Valuation report on Aarti Drugs LTD. is done keeping in mind a Value Equity philosophy, which is based on the belief that all successful investing should thoughtfully weigh two important attributes of a stock: price and prospects. Since some value managers tend to focus almost exclusively on stock price, they often underestimate the importance of prospects. However, we believe a company’s prospective ability to generate high cash flow returns on capital will strongly influence investment success. In our view, using a strong valuation discipline to purchase well-positioned, cash generating businesses run by shareholder-oriented management teams is the best formula for long-term portfolio performance. | en_US |
dc.language.iso | en_US | en_US |
dc.relation.ispartofseries | TD-2213; | - |
dc.subject | DRUGS LTD | en_US |
dc.subject | CASH FLOW | en_US |
dc.subject | MARKETING | en_US |
dc.title | AARTI DRUGS LTD. FINANCIAL ANALYSIS AND PROPOSED ACQUISITION | en_US |
dc.type | Thesis | en_US |
Appears in Collections: | MBA |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
VivekDabodiya final.pdf | 941.03 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.